Clinical Trial Update: Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis [Phase 2]

View source ↗

Summary

Phase II trial update for Enbrel in patients with primary systemic amyloidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Primary Systemic Amyloidosis | Phase 2 | Status: COMPLETED